Clinical Trials Logo
  1. Home
  2. Antibiotic Resistance
  3. NCT02367339
  4. Details
NCT02367339 Clinical Trial

Assessment of the Prevalence of Extended-Spectrum Betalactamase Producing Enterobacteriaceae Among ICU Staff

Antibiotic Resistance Clinical Trial

— REASSE  

Official title:
Assessment of the Prevalence of Extended-Spectrum Betalactamase Producing Enterobacteriaceae Among ICU Staff

Clinical Trial Details — Status: Recruiting

Administrative data
NCT number NCT02367339
Other study ID # CHU-0224
Secondary ID
Status Recruiting
Phase N/A
First received February 12, 2015
Last updated February 19, 2015
Start date February 2015
Est. completion date May 2016

Study information
Verified date February 2015
Source University Hospital, Clermont-Ferrand
Contact Patrick LACARIN
Phone 04 73 75 11 95
Email placarin@chu-clermontferrand.fr
Is FDA regulated No
Health authority France: Commission nationale de l'informatique et des libertés
Study type Observational

Clinical Trial Summary

Evaluation of the prevalence of ESBL-Enterobacteriaceae colonization among ICU staff

Description:

Prospective epidemiological study with voluntary non-medical staff member (i.e. nurses and nursing assistants) and medical staff in two French ICUs.

Assessment of self-reported risk factors for MDR-bacteria colonization. Self-performed rectal swab with isolation of ESBL-producting Enterobacteriaceae, identification of bacterial species and antibiotic suspectibilities.

Characterization of Escherichia coli ESBL.

Recruitment information / eligibility
Status Recruiting
Enrollment 100
Est. completion date May 2016
Est. primary completion date May 2016
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

- volunteers

Exclusion Criteria:

Study Design

Time Perspective: Prospective

Related Conditions & MeSH terms

Intervention

Other:
• ESBL
Evaluation of the prevalence of ESBL-Enterobacteriaceae colonization among ICU staff

Locations
Country Name City State
France CHU de Clermont-Ferrand Clermont-Ferrand

Sponsors (3)
Lead Sponsor Collaborator
University Hospital, Clermont-Ferrand Hopital Gabriel Montpied, University Hospital, Estaing

Country where clinical trial is conducted

France, 

Outcome
Type Measure Description Time frame Safety issue
Primary Digestive tract colonization by ESBL Digestive tract colonization by ESBL-producing Enterobacteriaceae on 1 faeces sample at day 1 No
See also
  Status Clinical Trial Phase
Active, not recruiting NCT03174236 - First Line Antimicrobials in Children With Complicated Severe Acute Malnutrition Phase 3
Recruiting NCT02566928 - Patient-Centered Comparative Effectiveness Research (CER) Study of Home-based Interventions to Prevent CA-MRSA Infection Recurrence Phase 4
Completed NCT05195866 - CRP for Respiratory Diagnosis in Kyrgyz Pediatric Practice N/A
Recruiting NCT04544072 - Analysis of the Quality and Quantity of Antibiotic Prescriptions for Bacterial Respiratory Tract Superinfection in Patients Hospitalized in COVID-19 Wards
Recruiting NCT04750655 - Antibiotic Resistance In Eye Surgeries Phase 4
Completed NCT04028830 - Impact on Antibiotic Prescriptions of a Bundle Intervention Conducted by Medical Representatives in General Practitioner Facilities, Based on Operational Demonstration of an Internet Decision Support Tool: Antibioclic N/A
Completed NCT03790254 - D Mannose for Prevention and Treatment of RUTIs
Not yet recruiting NCT05606627 - Correlation Between Antibiotic Resistance and Incidence of Sepsis in Community Acquired Pneumonia
Completed NCT02591901 - Preventing UTIs in Chronic Neurogenic Bladder Dysfunction (Mix Methods) Phase 2
Not yet recruiting NCT06371560 - Antibiotics, Antibiotic Resistance, and Prescribing Practices Among Periodontists: Cross Sectional KAP Study